₹867.45
▼ -15.9 -1.80%
17 Jul 2026
NSE Listed
Sudeep Pharma Limited (SUDEEPPHRM)
Volume: 1,70,677Avg Vol 1W: 1,61,588.8Avg Vol 1M: 2,14,809.0552W Range:₹524.05₹894.95
Key Ratios
Checked 6h agoMarket Cap₹9,977 Cr
Current Price₹867.45
Previous Close₹883.35
High / Low (52w)₹894.95 / ₹524.05
Volume1,70,677
Avg Vol (1W)1,61,588.8
Avg Vol (1M)2,14,809.05
Stock P/E201.68
Book Value₹78.21
Dividend Yield0%
ROE19.57%
ROA14.83%
Revenue (TTM)₹511 Cr
Revenue Growth9.3%
Profit Margin26.92%
Total Debt₹40 Cr
Shares Outstanding11 Cr
Face Value₹1
EPS (TTM)₹15.31
P/B11.3
Debt / Equity0.21
50 DMA₹783.69
200 DMA₹678.94
Day change-1.80%
Price Chart
₹867.45▲ 12.05% · 1Y
2025-11-282026-07-16
20-day avg volume: 2.1L shares
Pros
- Healthy return on equity of 19.6%.
- Company is almost debt-free.
Cons
- Revenue fell 42% YoY.
- Stock trades at a high P/E of 202.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹149 Cr | ₹116 Cr | ₹158 Cr | ₹125 Cr | ₹163 Cr | ₹172 Cr | ₹182 Cr |
| EBITDA | ₹63 Cr | ₹39 Cr | ₹60 Cr | ₹46 Cr | ₹62 Cr | ₹63 Cr | ₹65 Cr |
| Net Profit | ₹49 Cr | ₹29 Cr | ₹44 Cr | ₹31 Cr | ₹46 Cr | ₹47 Cr | ₹49 Cr |
| EPS | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Revenue | ₹126 Cr | ₹219 Cr | ₹350 Cr | ₹438 Cr | ₹465 Cr | ₹511 Cr |
| EBITDA | ₹26 Cr | ₹44 Cr | ₹70 Cr | ₹91 Cr | ₹179 Cr | ₹189 Cr |
| Net Profit | ₹18 Cr | ₹33 Cr | ₹50 Cr | ₹62 Cr | ₹133 Cr | ₹139 Cr |
| EPS | 128.02 | 236.61 | 356.01 | 5.74 | 12.28 | 12.78 |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Total Assets | ₹131 Cr | ₹213 Cr | ₹344 Cr | ₹420 Cr | ₹514 Cr | ₹717 Cr |
| Total Liabilities | ₹50 Cr | ₹99 Cr | ₹180 Cr | ₹197 Cr | ₹158 Cr | ₹224 Cr |
| Equity | ₹81 Cr | ₹114 Cr | ₹163 Cr | ₹223 Cr | ₹356 Cr | ₹493 Cr |
| Total Debt | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Operating | ₹16 Cr | ₹46 Cr | ₹15 Cr | ₹71 Cr | ₹110 Cr | ₹89 Cr |
| Investing | ₹-22 Cr | ₹-40 Cr | ₹-38 Cr | ₹-50 Cr | ₹-49 Cr | ₹-79 Cr |
| Financing | ₹12 Cr | ₹13 Cr | ₹51 Cr | ₹-10 Cr | ₹-13 Cr | ₹53 Cr |
| Free Cash Flow | ₹16 Cr | ₹46 Cr | ₹15 Cr | ₹71 Cr | ₹110 Cr | ₹89 Cr |
Shareholding
Promoter 76.15% Institutions 17.46% Public 6.39%
Efficiency & Working Capital
ROCE22.2%
Interest Coverage27.8
Dividend Payout—
Debtor Days135 d
Inventory Days94 d
Payable Days44 d
Cash Conversion Cycle184 d
Working Capital Days228 d
Shareholding Details
As of 2026-06-30
Promoter76.2%
FII1.8%
DII15.6%
Institutions17.5%
Public6.4%
Promoter Pledge0%
No. of Shareholders35,695
Shareholding Pattern
Quarterly — figures in %. Latest 6 quarters.
| Period | Jun 2025 | Nov 2025 | Nov 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 91.1% | 76.2% | 76.2% | 76.2% | 76.2% | 76.2% |
| FIIs | 0% | 0.9% | 1.5% | 1.7% | 1.6% | 1.8% |
| DIIs | 0% | 14.8% | 14.8% | 17.6% | 18.1% | 15.6% |
| Public | 8.9% | 8.2% | 7.5% | 4.6% | 4.2% | 6.4% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 16 | 2,17,982 | 2,17,982 | 43,599 | 36,503 | 35,695 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Riva Resources Private Limited | Shareholding of Promoter and Promoter Group | 40.4% | 4.56 Cr |
| Bhayani Sujit Jaysukh | Shareholding of Promoter and Promoter Group | 21.2% | 2.39 Cr |
| Sujeet Jaysukh Bhayani Huf | Shareholding of Promoter and Promoter Group | 5.7% | 64,60,747 |
| Avani Sujeet Bhayani | Shareholding of Promoter and Promoter Group | 4.5% | 50,53,140 |
| Shanil Sujit Bhayani | Shareholding of Promoter and Promoter Group | 4.5% | 50,25,000 |
| Nuvama Crossover Opportunities Fund - Series Iii | Public Shareholding | 3% | 33,37,482 |
| Nuvama Crossover Opportunities Fund - Series Iii A . | Public Shareholding | 2.6% | 29,02,744 |
| Nuvama Crossover Opportunities Fund - Series Iii B . | Public Shareholding | 2.1% | 24,16,427 |
| Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund A/c Axis Small Cap Fund | Public Shareholding | 1.9% | 20,85,880 |
| Mukul Mahavir Agrawal | Public Shareholding | 1.3% | 15,00,117 |
| Sbi Healthcare Opportunities Fund | Public Shareholding | 1.2% | 13,60,000 |
| Jaysukh Jayantilal Bhayani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Dipen Jaysukh Bhayani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Urvir Jaysukh Bhayani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rhea Sujit Bhayani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Anjana Rajendrabhai Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rajendra Chunilal Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Vidhi Shanil Bhayani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Inaraa Shanil Bhayani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Alka Pravinchandra Kotak | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Pravinchandra Talakshibhai Kotak | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Harsh Pravinbhai Kotak | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Dipen Jaysukh Bhayani Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Urvir Jaysukh Bhayani Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Pravinbhai Talkshibhai Thakkar Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Bhayani Sujit Jaysukh | 0 | 0% | 2026-06-30 |
| Sujeet Jaysukh Bhayani Huf | 0 | 0% | 2026-06-30 |
| Avani Sujeet Bhayani | 0 | 0% | 2026-06-30 |
| Shanil Sujit Bhayani | 0 | 0% | 2026-06-30 |
| Jaysukh Jayantilal Bhayani | 0 | 0% | 2026-06-30 |
| Dipen Jaysukh Bhayani | 0 | 0% | 2026-06-30 |
| Urvir Jaysukh Bhayani | 0 | 0% | 2026-06-30 |
| Rhea Sujit Bhayani | 0 | 0% | 2026-06-30 |
| Anjana Rajendrabhai Patel | 0 | 0% | 2026-06-30 |
| Rajendra Chunilal Patel | 0 | 0% | 2026-06-30 |
| Vidhi Shanil Bhayani | 0 | 0% | 2026-06-30 |
| Inaraa Shanil Bhayani | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Sujit J Bhayani | Chairman & Managing Director | 2025 |
| Shanil Sujit Bhayani | Whole-time Director | 2025 |
| Ajay Shrirang Kandelkar | Whole-time Director | 2025 |
| Samaresh Panda | Independent Director | 2025 |
| S. Raghunandan | Independent Director | 2025 |
| Reshma Patel | Independent Director | 2025 |
| Sujit Gulati | Independent Director | 2025 |
| Dimple Mehta | Company Sec. & Compli. Officer | 2025 |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹153 Cr | 43% |
| USA | ₹55 Cr | 15.4% |
| Others | ₹148 Cr | 41.6% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹1 | 12 | 11 | 11 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-23 | Dividend (1.5/- per share) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 676 | 0 | 0 | 3 | 39 | 718 |
| 2026 | 308 | 0 | 0 | 0 | 0 | 308 |
| 2026 | 16 | 0 | 0 | 3 | 38 | 57 |
Company Information
🌐 www.sudeeppharma.com ↗
📍 129/1/A GIDC Estate Nandesari, Vadodara, Gujarat, 391340
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search